Page 2 - Purchase Additional News Today

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

Message : Required fields Eloxx Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters Option to Purchase Additional Shares WALTHAM, Mass., May 18, 2021 (GLOBE NEWSWIRE) - Eloxx Pharmaceuticals, Inc. (the Company) (Nasdaq: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced the closing of an underwritten public offering of 38,333,334 shares of common stock at a public offering price of $...

Message : Required fields Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares HIGHLANDS RANCH, Colo., May 11, 2021 - Vivos Therapeutics, Inc. (Nasdaq: VVOS) (Vivos), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced the closing of its ...

Administration to Purchase Additional 200 Million Doses to Be Delivered This Summer This afternoon, President Biden will outline his vision and new elements of his agenda for advancing racial equity for Americans who have been underserved and left behind. Equal opportunity is the fundamental promise of America. But systemic racism and discrimination in our economy, laws, and institutions have put the promise of America out of reach for too many families of color.   President Biden will renew t...

Administration to Purchase Additional 200 Million Doses to Be Delivered This Summer Just over a year since the first COVID-19 case was confirmed in the United States, the nation has hit another grim milestone in the pandemic, reaching 25 million infections and counting. The pace in which this virus has spread throughout the U.S. is staggering and with new variants emerging, the spread is not slowing any time soon. That’s why it is critical that we vaccinate as many people as possible, as quic...

[December 28, 2020] Arvinas, Inc. Announces Exercise of Underwriters Option to Purchase Additional Shares NEW HAVEN, Conn., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation using its PROTAC ® Discovery Engine, today announced that the underwriters of its previously announced underwritten public offering of common stock, which closed on December 18, 2020, have exercised in...

Seaspan Corporation (CNW Group/Atlas Corp.) Offering includes $26.25 Million Full Exercise of Option to Purchase Additional Notes LONDON, Dec. 22, 2020 /PRNewswire/ - Atlas Corp. ("Atlas") (NYSE: ATCO) announced that its wholly-owned subsidiary, Seaspan Corporation ("Seaspan" or the "Company"), closed its previously announced offering (the "Offering") of 3.75% exchangeable senior notes due 2025 (the "notes") in a private placement to persons reasonably believed to be qualified institutional buy...

NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN : FR0011341205 – the ‘‘ Company’’), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the pricing of its initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares (the “ New Shares”), consisting of a public offering of 5,445,000 ordinary shares in the form of American Depositary Shares (“ ADSs”), each represen...